Skip to main content
. 2018 Feb 9;45(3):443–456. doi: 10.1007/s10928-018-9574-0

Fig. 5.

Fig. 5

Results for Scenario 1—Predicted plasma concentration of amlodipine (AML) (a) and systolic blood pressure (b) using a physiologically-based pharmacokinetic (PBPK)/pharmacodynamic (PD) model for a ritonavir (RTV)-amlodipine once daily (QD) dosage regimen with (green line) and without (pink line) amlodipine dose adjustment (Color figure online)